Cargando…
Design of Synthetic Surrogates for the Macrolactone Linker Motif in Coibamide A
[Image: see text] A marine cyanobacterial cyclic depsipeptide, coibamide A (CbA), inhibits the mammalian protein secretory pathway by blocking the Sec61 translocon, which is an emerging drug target for cancer and other chronic diseases. In our previous structure–activity relationship study of CbA, t...
Autores principales: | Suzuki, Rikito, Mattos, Daphne R., Kitamura, Takashi, Tsujioka, Rina, Kobayashi, Kazuya, Inuki, Shinsuke, Ohno, Hiroaki, Ishmael, Jane E., McPhail, Kerry L., Oishi, Shinya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578308/ https://www.ncbi.nlm.nih.gov/pubmed/37849553 http://dx.doi.org/10.1021/acsmedchemlett.3c00232 |
Ejemplares similares
-
Design of Coibamide A Mimetics with Improved Cellular
Bioactivity
por: Kitamura, Takashi, et al.
Publicado: (2021) -
Coibamide A Targets Sec61 to Prevent Biogenesis of
Secretory and Membrane Proteins
por: Tranter, Dale, et al.
Publicado: (2020) -
The Marine-Derived Macrolactone Mandelalide A Is an Indirect Activator of AMPK
por: Mattos, Daphne R., et al.
Publicado: (2022) -
ATG5 Promotes Death Signaling in Response to the Cyclic Depsipeptides Coibamide A and Apratoxin A
por: Wan, Xuemei, et al.
Publicado: (2018) -
Coibamide A Induces mTOR-Independent Autophagy and Cell Death in Human Glioblastoma Cells
por: Hau, Andrew M., et al.
Publicado: (2013)